L-ARGININE HYDROCHLORIDE
Sponsors
Universitaetsklinikum Erlangen AöR, Rayzebio Inc., Menzies School of Health Research, Claudia R. Morris, Xijing Hospital
Conditions
Acute Kidney InjurySevere Falciparum MalariaSickle Cell Diseasegastro-enteropancreatic neuroendocrine tumors (GEP-NETs)type 2 diabetes mellitus
Phase 2
Phase 3
Sickle Cell Disease Treatment With Arginine Therapy (STArT) Trial
CompletedNCT04839354
Start: 2021-06-21End: 2024-07-11Updated: 2025-07-30
Effects of Finerenone on Renal Hemodynamics and Oxidative Stress
CompletedCTIS2023-508266-15-00
Start: 2024-01-18End: 2025-11-25Target: 75Updated: 2024-08-16
Trial title: Phase 1b/3 global, randomized, controlled, open-label trial comparing treatment with RYZ101 to standard of care (SoC) therapy in subjects with inoperable, advanced, somatostatin receptor expressing (SSTR+), well-differentiated gastro-enteropancreatic neuroendocrine tumors (GEP-NETs) that have progressed following prior 177Lu-labelled somatostatin analogue (177Lu-SSA) therapy (ACTION-1)
RecruitingCTIS2023-509334-19-00
Start: 2024-10-17Target: 78Updated: 2025-08-22